NIH – Policy & Medicine

NIH Scientific Integrity Policy 2024: Eliminates Detailed Sections on Financial Conflicts Adds Focus on Political Influence and DEIA

HHS OIG Report Finds Gaps in the NIH Grant Management System

HHS OIG Finds that NIH Fails to Hold Researchers Accountable

HHS OIG Audit Finds that NIH Did Not Ensure All Clinical Trial Results Were Reported as Required

HHS OIG Identifies Opportunities to Strengthen NIH Grantees’ Oversight of Investigators’ Foreign Financial Interests

NIH Announces Public Private Partnership for COVID-19 Response

FDA and NIH Don’t Always Enforce Clinical Trial Transparency Regulations

21st Century Cures Update – Includes Exemption for Education in Open Payments

New Rule and Guidance Issued on Clinical Trials

NIH Asks for Input on NCAB Cancer Moonshot Blue Ribbon Panel